Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin

Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. And they’re doubling down.

Bristol Myers Squibb's first AI cluster has significantly accelerated drug discovery processes, demonstrating the transformative impact of AI in pharmaceuticals.